Drug intelligence / Profile preview

notoginsenoside Fe

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Notoginsenoside Fe is a minor dammarane-type triterpenoid saponin primarily isolated from the roots, leaves, and flowers of *Panax notoginseng* and *Panax japonicus*. It is frequently identified as a bioactive metabolite generated through the biotransformation of major ginsenosides, such as ginsenoside Rc, by gut microbiota or specific enzymatic processes. Research has highlighted its potential therapeutic utility in metabolic disorders, particularly obesity, where it has been shown to reduce food intake and body weight by activating energy-sensing neurons in the paraventricular nucleus (PVH) of the hypothalamus. Beyond its metabolic effects, notoginsenoside Fe exhibits anti-inflammatory, hemostatic, and anti-tumor activities. It has been studied for its ability to inhibit xanthine oxidase, making it a candidate for gout treatment, and for its inhibitory effects on lung adenocarcinoma cell proliferation. It is also a component of several traditional Chinese medicine (TCM) formulations investigated for acute lung injury and type 2 diabetes.

Other names
notoginsenoside FeN-Fe
02

Targets

STAT3 (Signal Transducer and Activator of Transcription 3)JUN (Transcription factor Jun)CASP3 (Caspase-3)XO (Xanthine Oxidoreductase)VEGFA (Vascular endothelial growth factor A)MMP9 (Matrix metalloproteinase-9)

Beyond the preview

Go deeper on notoginsenoside Fe.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on notoginsenoside Fe.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call